Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $8.92 | 52-week high | $16.27 |
Prev. close | $8.69 | 52-week low | $7.88 |
Day low | $8.88 | Volume | 500 |
Day high | $8.92 | Avg. volume | 2,620 |
50-day MA | $9.69 | Dividend yield | N/A |
200-day MA | $12.74 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
Issuer | Range ETFs |
Expense Ratio | 0.79% |
Underlying Index | Range Cancer Therapeutics Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 6.96M |
Net Asset Value (NAV) | $8.92 |
Options? | Yes |
Total Holdings | N/A |
CNCR Price Returns
1-mo | 0.56% |
3-mo | -29.82% |
6-mo | -33.38% |
1-year | -41.58% |
3-year | -39.93% |
5-year | -62.83% |
YTD | -27.54% |
2024 | -8.61% |
2023 | -1.89% |
2022 | -42.31% |
2021 | -19.24% |
2020 | 36.53% |